MogamulizumabHepatitis B reactivation and cytomegalovirus-related infections: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1848卷 / 1期

关键词：

D O I：

10.1007/s40278-021-93270-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：268 / 268

相关论文

共 50 条

[1] Immunosuppressants/linezolidPulmonary nocardiosis, cytomegalovirus-related erosive gastritis and GI intolerance: 3 case reports
Reactions Weekly, 2021, 1880 (1) : 211 - 211
[2] GolimumabRenal cancer, cytomegalovirus reactivation and cholecystitis: 3 case reports
Reactions Weekly, 2025, 2046 (1) : 176 - 176
[3] EtanerceptHepatitis B reactivation: 3 case reports
Reactions Weekly, 2012, 1401 (1) : 17 - 17
[4] Multiple drugsImmune related colitis and cytomegalovirus infection reactivation: 5 case reports
Reactions Weekly, 2017, 1681 (1) : 249 - 249
[5] Carboplatin/mogamulizumabHepatitis B virus reactivation (first report with mogamulizumab): case report
Reactions Weekly, 2014, 1495 (1) : 14 - 14
[6] Multiple drugsCheckpoint inhibitor related pneumonitis and cytomegalovirus reactivation: 12 case reports
Reactions Weekly, 2021, 1846 (1) : 209 - 209
[7] ImmunosuppressantsHepatitis B virus reactivation: 3 case reports
Reactions Weekly, 2019, 1764 (1) : 172 - 172
[8] Antineoplastics/lamivudineHepatitis B reactivation: 3 case reports
Reactions Weekly, 2014, 1514 (1) : 10 - 10
[9] Methotrexate/ustekinumabHepatitis B reactivation: 3 case reports
Reactions Weekly, 2018, 1726 (1) : 235 - 235
[10] PrednisoloneHepatitis B virus reactivation: 3 case reports
Reactions Weekly, 2022, 1887 (1) : 584 - 584

← 1 2 3 4 5 →